← Leaderboards
Serge Y Fuchs
University Of Pennsylvania
$17,647,204
Attributed
$20,122,214
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,122,214 · 12
By mechanism
R01$16,813,859 · 8
P01$2,879,719 · 3
R21$428,636 · 1
Top collaborators
- Dmitry Isaac Gabrilovich4 shared
- Yulia Nefedova3 shared
- Michael S Cohen2 shared
- Vladimir S. Spiegelman2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Amos B Smith$26,356,961
- Qin Yu$7,039,104
- Ravi K Amaravadi$13,477,656
- Aaron Robert Goldman$1,293,622
- Angelica Ortiz$111,360
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsDown-RegulationResponseReceptorTumorPathway InteractionsMediatingMalignant NeoplasmsSignal TransductionInterferonsCytokineIfnar1 GenePlayBaseInterferon-AlphaUbiquitinationPhosphorylationTumorigenicInterferon Type IMouse ModelGeneticMutantNeoplastic CellInsight
Grant awards (62)
Targeting Ã-TrCP regulators to improve CRC response to chemotherapy$673,747
R01 · FY2025 · CA
Targeting immunosuppression of intratumoral CAR T cells$509,474
R01 · FY2025 · CA · contact PI
Targeting Ã-TrCP regulators to improve CRC response to chemotherapy$701,596
R01 · FY2024 · CA
Targeting immunosuppression of intratumoral CAR T cells$527,840
R01 · FY2024 · CA · contact PI
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy$353,134
R01 · FY2024 · CA · contact PI
Type I Interferon Pathway in Pancreatic Adenocarcinoma$347,592
R01 · FY2024 · CA · contact PI
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy$364,284
R01 · FY2023 · CA · contact PI
Type I Interferon Pathway in Pancreatic Adenocarcinoma$358,569
R01 · FY2023 · CA · contact PI
Project 3- Integrated Stress and Interferon Responses$294,512
P01 · FY2023 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$461,819
R01 · FY2022 · CA
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy$364,284
R01 · FY2022 · CA · contact PI
Type I Interferon Pathway in Pancreatic Adenocarcinoma$358,569
R01 · FY2022 · CA · contact PI
Project 3- Integrated Stress and Interferon Responses$220,450
P01 · FY2022 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$471,244
R01 · FY2021 · CA
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy$371,338
R01 · FY2021 · CA · contact PI
Type I Interferon Pathway in Pancreatic Adenocarcinoma$365,086
R01 · FY2021 · CA · contact PI
Role of HOS in Cell Transformation and Apoptosis$344,138
R01 · FY2021 · CA · contact PI
Project 3- Integrated Stress and Interferon Responses$296,020
P01 · FY2021 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$547,478
R01 · FY2020 · CA
Type I Interferon Pathway in Pancreatic Adenocarcinoma$379,268
R01 · FY2020 · CA · contact PI
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy$370,575
R01 · FY2020 · CA · contact PI
Role of HOS in Cell Transformation and Apoptosis$344,138
R01 · FY2020 · CA · contact PI
Project 3- Integrated Stress and Interferon Responses$295,261
P01 · FY2020 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$457,106
R01 · FY2019 · CA
Role of HOS in Cell Transformation and Apoptosis$333,813
R01 · FY2019 · CA · contact PI
Project 3- Integrated Stress and Interferon Responses$295,109
P01 · FY2019 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$79,154
R01 · FY2019 · CA
Negative regulation of myeloid-derived suppressive cells in cancer$493,744
R01 · FY2018 · CA
Role of HOS in Cell Transformation and Apoptosis$344,138
R01 · FY2018 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$26,818
R01 · FY2018 · CA
Role of HOS in Cell Transformation and Apoptosis$344,138
R01 · FY2017 · CA · contact PI
UPR, interferon signaling and tumorigenesis$279,914
P01 · FY2017 · CA · contact PI
UPR, interferon signaling and tumorigenesis$282,566
P01 · FY2016 · CA · contact PI
UPR, interferon signaling and tumorigenesis$305,838
P01 · FY2015 · CA · contact PI
Role of HOS in Cell Transformation and Apoptosis$254,682
R01 · FY2015 · CA · contact PI
Interferon Responses in Myeloid Leukemia$312,379
R01 · FY2014 · CA · contact PI
UPR, interferon signaling and tumorigenesis$300,424
P01 · FY2014 · CA · contact PI
Role of HOS in Cell Transformation and Apoptosis$247,041
R01 · FY2014 · CA · contact PI
UPR, interferon signaling and tumorigenesis$309,625
P01 · FY2013 · CA · contact PI
Interferon Responses in Myeloid Leukemia$302,718
R01 · FY2013 · CA · contact PI
Role of HOS in Cell Transformation and Apoptosis$239,401
R01 · FY2013 · CA · contact PI
Interferon Responses in Myeloid Leukemia$322,040
R01 · FY2012 · CA · contact PI
Role of HOS in Cell Transformation and Apoptosis$254,682
R01 · FY2012 · CA · contact PI
Interferon Responses in Myeloid Leukemia$322,040
R01 · FY2011 · CA · contact PI
Role of HOS in Cell Transformation and Apoptosis$269,682
R01 · FY2011 · CA · contact PI
Interferon Responses in Myeloid Leukemia$332,000
R01 · FY2010 · CA · contact PI
Stability of prolactin receptor and prolactin signaling$255,767
R01 · FY2010 · CA · contact PI
Stability of prolactin receptor and prolactin signaling$297,767
R01 · FY2009 · CA · contact PI
Role of HOS in cell transformation and apoptosis$253,876
R01 · FY2009 · CA · contact PI
Stability of prolactin receptor and prolactin signaling$255,767
R01 · FY2008 · CA · contact PI
Role of HOS in cell transformation and apoptosis$253,876
R01 · FY2008 · CA · contact PI
Regulation of interferon receptor by Leishmania kinase$231,761
R21 · FY2008 · AI · contact PI
Stability of prolactin receptor and prolactin signaling$255,713
R01 · FY2007 · CA · contact PI
Role of HOS in cell transformation and apoptosis$253,742
R01 · FY2007 · CA · contact PI
Regulation of interferon receptor by Leishmania kinase$196,875
R21 · FY2007 · AI · contact PI
Stability of prolactin receptor and prolactin signaling$291,170
R01 · FY2006 · CA · contact PI
Role of HOS in cell transformation and apoptosis$260,628
R01 · FY2006 · CA · contact PI
Role of HOS in cell transformation and apoptosis$266,900
R01 · FY2005 · CA
Role of HOS in cell transformation and apoptosis$273,413
R01 · FY2004 · CA
Role of HOS in cell transformation and apoptosis$249,638
R01 · FY2003 · CA
Role of HOS in cell transformation and apoptosis$249,638
R01 · FY2002 · CA
Role of HOS in cell transformation and apoptosis$246,215
R01 · FY2001 · CA